US FDA expands approval for Johnson & Johnson HIV drug.
D000069454:Darunavir; D017277:Drug Approval; D017320:HIV Protease Inhibitors; D013449:Sulfonamides; D014481:United States; D014486:United States Food and Drug Administration
D017320:HIV Protease Inhibitors; D013449:Sulfonamides; D000069454:Darunavir